drugset
drugset / Trial / NCT07577479

A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

NCT07577479 ↗

Phase 1 Active not recruiting 24 enrolled Shanghai Argo Biopharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

Timeline

Start
2026-05-18
Primary completion
2027-06-30
Completion
2028-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BW-50218 Unknown — —

Indications

No indication recorded.